Detall de l'activitat


XVIII Congress of the Catalan Society of Immunology: Cross-talk between anatomical barriers and the immune system
Societat Catalana d'Immunologia
21 i 22 de novembre de 2024 | Auditori | Acadèmia Can Caralleu
Abstracts
Inscripcions
Instruccions presentació pòsters
Programa

Can Caralleu

Carrer Major de Can Caralleu, 1-7

08017 Barcelona

Dijous, 21 de novembre de 2024 | 15:00 - 20:00
15:00 - 15:15
Welcome to the XVIII Congress of the SCI > Can Caralleu - Auditori
Presentador:
Francisco Lozano Soto. President of the SCI
15:15 - 16:45
OPENING SESSION > Can Caralleu - Auditori
Integration of surfactant in the innate defense of the pulmonary barrier
Ponent:
Cristina Casals. Group of Cellular and Molecular Biology in the Alveolus, Department ofBiochemistry and Molecular Biology, Universidad Complutense de Madrid, Madrid, Spain
Intestinal immune responses shape mucosal barriers: implicationsforinflammatory bowel disease
Ponent:
Azucena Salas. Inflammatory Bowel Disease Unit, Hospital Clínic de Barcelona, Institutd'Investigacions Biomèdiques August Pi i Sunyer
16:00 - 20:00
XVIII Congress of the Catalan Society of Immunology: Cross-talk between anatomical barriers and the immune system
16:45 - 17:15
COFFEE BREAK - POSTERS > Can Caralleu - Auditori
17:15 - 19:00
ORAL COMMUNICATIONS - SESSION I: Autoimmunity > Can Caralleu - Auditori
Applying single-cell omics technologies to unravel the impact of E. coli onCrohn'sdisease immunopathology
Ponent:
Núria Gumà-Vique. Hospital del Mar Research Institute, Barcelona, Spain
Neutrophil heterogeneity increases in the colon of active Inflammatory Bowel Diseasepatients in response to local inflammatory cues
Ponent:
Marisol Veny. Institut d’Investigacions Biomèdiques AugustPi iSunyer
Expanding the landscape of systemic sclerosis-related autoantibodies throughRNAimmunoprecipitation coupled with massive parallel sequencing
Ponent:
Janire Perurena-Prieto. Immunology Division, Vall d’Hebron University Hospital
Increasing contribution of mitochondria-derived peptides to the HLA-DRimmunopeptidome on different T1D stages
Ponent:
Manel García-Ayala. Insitut de Biotecnologia i Biomedicina, Universitat Autònoma deBarcelona
Identifying mice Aged-associated B cells (ABCs) in human SLE patients
Ponent:
Anna Calvet Lacruz. Hospital de la Santa Creu i Sant Pau, Servei d'Immunologia, Barcelona
An innovative nanoparticle-based immunotherapy targeting iTTP: restoringself- tolerance with autoantigen-loaded liposomes
Ponent:
Daniela Greco
The importance of nodal and paranodal antibodies in monitoring and treatment inautoimmune nodopathies
Ponent:
Andrea Bravo Gómez. Immunology Department. Hospital de la Santa Creu i Sant Pau, Barcelona
Divendres, 22 de novembre de 2024 | 08:00 - 20:10
08:00 - 19:00
XVIII Congress of the Catalan Society of Immunology: Cross-talk between anatomical barriers and the immune system
09:30 - 10:10
PLENARY SESSION I > Can Caralleu - Auditori
Back to the source in Atopic Dermatitis: CLA+ memory T cells and skin cell interaction allows patient stratification and endotyping
Ponent:
Luis Santamaría-Babí. Translational Immunology, Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, University of Barcelona, Parc Científic de Barcelona
10:10 - 10:40
COFFEE BREAK - POSTERS > Can Caralleu - Auditori
10:40 - 12:00
ORAL COMMUNICATIONS - SESSION II: Immunodeficiencies and Inflammation > Can Caralleu - Auditori
TRAF3 deficiency: From Herpes Simplex Encephalitis to B cell dysregulation syndrome
Ponent:
Laura Batlle-Masó. Translational Immunology Research Group, Vall d’Hebron, Barcelona
A novel pathogenic variant in SASH3 gene in a patient with late-onset CID and immune dysregulation
Ponent:
Elisabet Pol Pol. Servei d'Immunologia. Hospital Universitari Son Espases, Palma de Mallorca
Abatacept: our experience in a patient with long-term evolution CTLA4 haploinsufficiency
Ponent:
Teresa Franco Leyva. Hospital de la Santa Creu i Sant Pau, Servei d'Immunologia, Barcelona
Circulating memory CLA+ T-cell with IL-22 effector function in atopic dermatitis stratifies patients with distinct lesional transcriptomics, plasma proteomics and epidermal hyperplasia
Ponent:
Irene García Jiménez. Immunologia Translacional, Departament de Biologia Cel·lular, Fisiologia i Immunologia, Barcelona
Exploring the association between eosinophil counts and autoimmunity in Chronic Obstructive Pulmonary Disease
Ponent:
Alejandro Torvisco Tello. Biomedicine department, University of Barcelona, Barcelona
Non-neutralizing autoantibodies against type I interferons associated with increased risk of thrombotic complications in critical COVID-19 patients
Ponent:
Mario Framil Seoane. Servei d'Immunologia, Hospital Clínic, Barcelona
12:00 - 13:00
ORDINARY GENERAL MEETING - SOCIETAT CATALANA D’IMMUNOLOGIA > Can Caralleu - Auditori
13:00 - 14:00
LUNCH - POSTERS > Can Caralleu - Auditori
14:00 - 14:30
SPONSORED TALK > Can Caralleu - Auditori
Update of the new management guidelines for Cytomegalovirus in transplantation. Role of specific cellular immunity against CMV
Ponent:
Manuel Muro Amador. Hospital Clinico Universitario Virgen de la Arrixaca, Murcia
14:30 - 15:15
PLENARY SESSION II > Can Caralleu - Auditori
Maping human development one cell at a time
Ponent:
Roser Vento-Tormo. Wellcome Sanger Institute; Centre for Trophoblast Research, University of Cambridge, Cambridge, UK
15:15 - 16:30
ORAL COMMUNICATIONS - SESSION III: Transplantation and Infection > Can Caralleu - Auditori
A novel calculated Panel Reactive Antibody (cPRA) score calculator: Enhancing allocation for solid organ transplantation in the catalan population
Ponent:
Juan Francisco Luchoro. Department of Immunology, Centre de Diagnòstic Biomèdic, Hospital Clínic de Barcelona
Microvascular inflammation (MVI) of the renal allograft in the absence of HLA-DSAs and C4d deposition
Ponent:
Eduardo Gozálvez González. Hospital Clinic de Barcelona
Detection of potentially allo-reactive NK cells in kidney transplant recipients with or without microvascular inflammation
Ponent:
Elisenda Alari-Pahissa. Institut Hospital del Mar d’Investigacions Mèdiques, Barcelona
HLA genotype, HLA-G variants, and HLA-B leader dimorphism impact on virus immune response: Refining cell donor selection for virus-specific T cell therapy
Ponent:
Rut Mora-Buch
Salmonella typhimurium infection model in Wistar rats for immune function analysis
Ponent:
Ruth Forsten. Nutrition and Food Safety Research Institute (INSA-UB), Santa Coloma de Gramene
Scorpion venom components target ion channels and Toll-like receptors in macrophages
Ponent:
Dalila Khemili. Laboratory of Cellular and Molecular Biology, Faculty of Biological Sciences
16:30 - 17:00
COOFFE BREAK - POSTERS > Can Caralleu - Auditori
17:00 - 17:30
SPONSORED TALK > Can Caralleu - Auditori
Spectral Flow cytometry: A closer step to high dimensional immunology
Ponents:
Jaime Valentin Quiroga. IdiPAZ, Hospital Universitario La Paz
Iñaki Salvador. Vall d´Hebron instituto de Oncologia
17:30 - 19:00
ORAL COMMUNICATIONS - SESSION IV: Tumor Immunology > Can Caralleu - Auditori
Analysis of the HLA-DR Immunopeptidome Derived from Dendritic Cells Pulsed with Tumor Extracts
Ponent:
Gonzalo Lázaro. Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona
Therapeutic impact and reactivation of tumor immunity by MYC inhibition in KRASdriven NSCLC with diverse mutational landscapes
Ponent:
Íñigo González Larreategui. Vall d’Hebron Institute of Oncology (VHIO), Barcelona
Use of the TCR (T-cell receptor) as a biomarker for monitoring irAEs (immune-related adverse events) in breast cancer
Ponent:
Maitane Faus. Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona
Tracking changes in TRBV family repertoire in blood after administration of PD-1+ TILs to identify Tumor-Specific TCRs
Ponent:
Alejandro Ramírez-Chacón. Fundació de Recerca Clínic Barcelona, IDIBAPS, Barcelona
Characterizing TCR and gene expression diversity in NY-ESO-1-specific HLADRB3*02:02-restricted CD4+ T Cells from healthy donors using single-cell RNA and TCR sequencing
Ponent:
Berta Casanovas-Albertí. IDIBAPS, Barcelona
Differential CD6 mRNA expression associates with adverse prognostic markers in chronic lymphocytic leukemia patients
Ponent:
Laura Carrillo-Serradell. Immunoreceptors del Sistema Innat i Adaptatiu, IDIBAPS, Barcelona
19:00 - 19:40
PLENARY SESSION III > Can Caralleu - Auditori
Toward antibody therapeutics with increased tissue selectivity and brain penetration
Ponent:
Benjamí Oller Salvia. Institut Químic de Sarrià (IQS), Universitat Ramon Llull, Barcelona
19:40 - 20:10
Prize to the best communication and poster - Closing of the Congress > Can Caralleu - Auditori
Eva Martinez Cáceres. Vice-President of the SCI